GRAFT-VERSUS-HOST DISEASE (GVHD)

Clinical trials for GRAFT-VERSUS-HOST DISEASE (GVHD) explained in plain language.

Never miss a new study

Get alerted when new GRAFT-VERSUS-HOST DISEASE (GVHD) trials appear

Sign up with your email to follow new studies for GRAFT-VERSUS-HOST DISEASE (GVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 3 Not yet finished but already full! 2 Completed 1

New drug combo tested to tame dangerous transplant complication

Disease control Completed

This study tested whether adding the drug itacitinib to standard steroid treatment works better for controlling acute graft-versus-host disease (GVHD) in people who recently had a stem cell transplant. It involved 439 participants who developed moderate to severe GVHD. The goal w…

Matched conditions: GRAFT-VERSUS-HOST DISEASE (GVHD)

Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Mar 19, 2026 14:56 UTC

GRAFT-VERSUS-HOST DISEASE (GVHD)

Get alerted when new GRAFT-VERSUS-HOST DISEASE (GVHD) trials appear

New drug combo tested to tame dangerous transplant complication